$PFE Company News Here are the best-performing
Post# of 102450

Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Younger workers are driving employers to choose urban locations 10:54 a.m. Jan. 5, 2015 - Eliot Brown
Pfizer acquires Redvax for its potential herpes vaccine 8:17 a.m. Jan. 5, 2015 - Angela Chen
Run, don’t walk, away from this year’s top performer 8:29 a.m. Dec. 31, 2014 - Mark Hulbert
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
’Tis the season for buying stocks dumped for tax reasons 9:16 a.m. Dec. 24, 2014 - Michael Brush
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
What I learned with my 10 stock recommendations a year ago 6:00 a.m. Dec. 23, 2014 - Diana Furchtgott-Roth
How to find ‘winners’ among the worst S&P 500 stocks 5:22 p.m. Dec. 22, 2014 - Philip van Doorn
Stocking stuffers 12:27 p.m. Dec. 17, 2014 - Mark Hulbert
Boeing’s shares get lift from dividend hike, buyback 7:23 p.m. Dec. 15, 2014 - MarketWatch
U.S. stocks end choppy session lower 4:44 p.m. Dec. 15, 2014 - Barbara Kollmeyer
Pfizer, OPKO Health partner on growth-hormone treatment 1:50 p.m. Dec. 15, 2014 - Angela Chen
Opko Health's stock soars after Pfizer development agreement 8:15 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko's stock jumps 8.8% premarket after Pfizer development agreement 8:07 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko Health, Pfizer team up to develop Opko's GHD treatment 8:06 a.m. Dec. 15, 2014 - Tomi Kilgore
Drug makers face another $65 billion patent cliff 12:41 p.m. Dec. 10, 2014 - Russ Britt
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
Visa, Goldman Sachs powering Dow to 18,000 4:29 p.m. Dec. 5, 2014 - Tomi Kilgore
Dow Jones (DJIA) Today: Pfizer (PFE) Higher 12:00 p.m. Today - TheStreet.com
Bristol’s Lung Cancer Drug Aces Trial, Cheers Bulls 10:58 a.m. Today - Barrons.com
TiGenix: A Deeply Undervalued Stem Cells Company With Upcoming Catalysts 9:59 a.m. Today - Seeking Alpha
TiGenix: A Deeply Undervalued Stem Cell Company With Upcoming Catalysts 9:59 a.m. Today - Seeking Alpha
Deal Making In The Healthcare Industry 9:08 a.m. Today - Seeking Alpha
Medical Marijuana Goes to Market in Canada 3:10 a.m. Today - InvestorPlace.com
Argos Therapeutics Falls on Disappointing Phase IIb HIV Data - Analyst Blog 4:20 p.m. Jan. 12, 2015 - Zacks.com
Regeneron Can Generate 25% Upside for Investors 1:44 p.m. Jan. 12, 2015 - Barrons.com
3 Stocks Advancing The Drugs Industry 12:13 p.m. Jan. 12, 2015 - TheStreet.com
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com
Dow 30 Stock Roundup: Pfizer Acquires Redvax, Microsoft Launches Affordable Internet-ready Phone - Analyst Blog 2:48 p.m. Jan. 9, 2015 - Zacks.com
3 Pharma Stocks That Soared Past Pfizer in 2014 - Analyst Blog 2:30 p.m. Jan. 9, 2015 - Zacks.com
The Bullish and Bearish Case for Pfizer in 2015 10:37 a.m. Jan. 9, 2015 - 247WallSt.com
Update: Pfizer's Palbociclib Is Closer To Approval Than Expected 8:23 p.m. Jan. 8, 2015 - Seeking Alpha
FDA clears Daiichi-Sankyo anticoagulant 7:55 p.m. Jan. 8, 2015 - Seeking Alpha
Pfizer, FDA Continue Talks on Breast-Cancer Drug 1:13 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Approval appears likely for Pfizer breast cancer candidate 12:48 p.m. Jan. 8, 2015 - Seeking Alpha
Income Ideas for 2015 11:03 a.m. Jan. 8, 2015 - Barrons.com
Dow Jones (DJIA) Today: Pfizer (PFE) Higher 11:00 a.m. Jan. 8, 2015 - TheStreet.com
5 Potential Blockbuster Drugs Set To Launch In 2015 7:02 a.m. Jan. 8, 2015 - Investors Business Daily
23andMe Announces Collaboration with Pfizer Inc. to Conduct Genetic Research Through 23andMe's Research Platform 9:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
HemoShear Announces Collaboration with Pfizer Inc. To Help Identify and Predict Drug-Induced Vascular Injury for Early Stage Compounds 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Pfizer Provides Update on IBRANCE® (palbociclib) 8:31 a.m. Jan. 8, 2015 - BusinessWire - BZX
Repligen Receives Milestone Payment From Pfizer 7:30 a.m. Jan. 8, 2015 - GlobeNewswire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference 10:01 a.m. Jan. 6, 2015 - BusinessWire - BZX
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments 7:30 a.m. Jan. 6, 2015 - PR Newswire - PRF
Pfizer Acquires Redvax GmbH 7:30 a.m. Jan. 5, 2015 - BusinessWire - BZX
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cintas, Deere, Thermo Fisher and Pfizer 9:10 a.m. Dec. 19, 2014 - PR Newswire - PRF
Pan American Fertilizer (TSX.V: PFE, Frankfurt: 6GF) Provides an Update on its Operations and Audit Filings and Announces Transfer to NEX 12:48 p.m. Dec. 18, 2014 - ACCESSWIRE
Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia 8:00 a.m. Dec. 18, 2014 - BusinessWire - BZX
Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy 8:01 a.m. Dec. 17, 2014 - BusinessWire - BZX
Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts 10:00 a.m. Dec. 16, 2014 - BusinessWire - BZX
Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis 8:02 a.m. Dec. 16, 2014 - BusinessWire - BZX
Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology 6:30 p.m. Dec. 15, 2014 - BusinessWire - BZX
Pfizer Declares First-Quarter 2015 Dividend 12:06 p.m. Dec. 15, 2014 - BusinessWire - BZX
InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton 9:31 a.m. Dec. 15, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause 9:02 a.m. Dec. 10, 2014 - BusinessWire - BZX

